ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

EVH // Evolent Health Inc (Class A)

FA <GO> NYSE RQD COCKPIT → CIK 0001628908 ↗
Consumer Discretionary • Other Consumer Services
$4.25 ▼ -0.08 (-1.85%)
MKT CAP: $480.5M • VOL: 1.30M
EVH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
FY 2024
FILED 2024-12-31
FY 2023
FILED 2023-12-31
Revenue (Total Sales) $1.88B $2.55B $1.96B
YoY Revenue Growth % -26.6% +30.1% —
Gross Profit $399.9M $367.4M —
Gross Margin % 21.3% 14.4% —
Research & Development (R&D) — — —
Operating Income (EBIT) -$410.1M -$40.5M -$71.2M
Operating Margin % -21.9% -1.6% -3.6%
Net Income (GAAP) -$579.4M -$93.5M -$142.3M
EBITDA (Normalized) — — —
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) $38.8M $18.8M $142.6M
Capital Expenditures (CapEx) — — —
Free Cash Flow (FCF) $38.8M $18.8M $142.6M
FCF Margin % 2.1% 0.7% 7.3%
Return on Invested Capital (ROIC %) -26.3% -2.3% —
Cash & Short-Term Equivalents $151.9M $104.2M —
Total Debt (Short + Long Term) $970.5M $490.5M —
Total Stockholders' Equity $415.2M $1.00B —